CTOs on the Move

US Med-Equip

www.usme.com

 
US Med-Equip is the fastest growing provider of respiratory, neonatal, infusion and other medical devices. We partner with top hospitals across the nation to provide the highest quality movable medical equipment for patients in their care—diagnostic and clinical devices ranging from infusion pumps and patient monitors to ventilators, newborn incubators and more. From major medical centers to underserved rural hospitals, our partners take no chances and count on USME for their medical equipment rental, sales, delivery and service needs, so they can continue to do what they do best: take care of patients in need. Designated as a "Top Workplace," ...
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million
  • www.usme.com
  • 7028 Gessner Road
    Houston, TX USA 77040
  • Phone: 877.677.7767

Executives

Name Title Contact Details
Antonio Marin
Chief Information Officer Profile

Similar Companies

MagneVu

MagneVu is a Carlsbad, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Nemco Medical

Nemco Medical is a Hicksville, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ARMUS Corporation

ARMUS Corporation is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

O-Two Medical Technologies Inc

O-Two Medical Technologies Inc is a Mississauga, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

LumiThera

At LumiThera, we are committed to developing solutions to prevent vision loss and blindness, improve visual function and stop or slow the progression of blinding diseases of the eye. We will continue to innovate non-invasive approaches to address unmet medical needs. LumiThera, Inc. is a commercial-stage medical device company initially focused on treating patients affected by dry age-related macular degeneration. The Company`s expertise is in the application of photobiomodulation (“PBM”), using non-invasive light emitting diodes (“LED”) for acute and chronic ocular diseases and disorders. The Company is developing an ophthalmic LED office-based instrument to be used in multiple ocular conditions or disorders as non-invasive medical treatments. Three clinical studies have demonstrated clinical and pathological benefits of PBM in treating subjects with dry AMD. The recent TORPA II clinical trial results demonstrating improvements in clinical outcomes of vision and reduction of pathological “drusen” following imaging analysis were published in December 2016 in ACTA Ophthalmologica, a top peer-reviewed Ophthalmology journal. The company recently completed the LIGHTSITE I clinical trial,a thirty subject dry AMD study partially supported by the National Eye Institute. The Valeda LIght Delivery System is now available for sale in the European Economic Area. The Valeda Light Delivery System is CE Marked. The device is not for sale in the USA.